Today: 20 May 2026
Barclays share price ticks up as profit-target talk builds ahead of Feb. 10 results
26 January 2026
1 min read

Barclays share price ticks up as profit-target talk builds ahead of Feb. 10 results

London, Jan 26, 2026, 08:11 GMT — Regular session

  • Barclays stock (BARC) edged up 0.2% in early London trading.
  • Reuters reports UK lenders set to raise profit targets ahead of earnings season.
  • Barclays revealed new share buybacks set for cancellation as part of its ongoing programme.

Barclays shares ticked up on Monday following a Reuters report that Britain’s largest banks are expected to boost their profit targets in upcoming annual results.

Barclays shares (BARC) edged higher by roughly 0.2% to 481.2 pence in early moves, following a close at 480.3 pence, per Investing.com data.

Timing is key. Bank earnings reports and fresh targets are coming in the next few weeks, and investors have been piling into European lenders following a solid rally in the sector.

Sources close to the situation told Reuters that Barclays plans to raise its return on tangible equity target — a key profitability metric comparing earnings to tangible shareholder equity — beyond the current 12%+ goal set for 2026. Analysts say the bank could boost the target by as much as 200 basis points, with each basis point equaling 0.01 percentage point, Reuters reported.

Barclays highlighted ongoing buybacks in a regulatory filing, revealing it repurchased 3,516,385 ordinary shares for cancellation following a Jan. 23 purchase. The shares were bought at prices between 480.35p and 486.75p.

Since announcing its buyback program in October, the bank has been repurchasing shares—a move investors track closely since it boosts earnings per share by reducing the number of outstanding shares.

Rates and credit continue to drive the major shifts. “UK banks have seen earnings hold up longer than first thought, thanks to higher interest rates, solid credit quality, and stricter cost controls,” Peter Rothwell, KPMG UK’s head of banking, told Reuters. Reuters

Peers are shifting as well. Reuters reports that HSBC and NatWest are set to raise their profitability forecasts, while Jefferies suggests Lloyds might boost its longer-term targets.

But pushing targets higher carries risks. If growth falters or credit losses climb, that guidance could become a cap investors penalize. And even a suggestion that interest rates won’t remain “benign” may squeeze banks’ net interest income.

Barclays faces its next major test with full-year earnings due Feb. 10. Investors will be watching closely for updates on medium-term goals, buyback plans, and management’s take on investment banking fees and loan quality.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks
Previous Story

Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks

Rio Tinto stock price ticks up in London as iron ore slips and the Glencore clock looms
Next Story

Rio Tinto stock price ticks up in London as iron ore slips and the Glencore clock looms

Go toTop